Skip to main content
. 2023 Jun 8;13(4):511–516. doi: 10.1016/j.jobcr.2023.05.003

Table 4.

-Mean Clinical Indices in ChP Groups at different time interval post therapy.

Clinical parameter Group Baseline mean ± S.D 1 month p* value 3 months p* value 6 months p* value 12 months p* value
PD (mm) ChP1 3.42 ± 0.56 2.87 ± 0.52 0.353 2.53 ± 0.38 0.417 2.25 ± 0.33 0.32 2.18 ± 0.42 0.313
ChP2 3.56 ± 0.62 2.85 ± 0.45 2.67 ± 0.48 2.21 ± 0.41 2.19 ± 0.44
CAL (mm) ChP1 5.18 ± 0.32 4.21 ± 0.28 0.331 3.56 ± 0.53 0.473 3.32 ± 0.58 0.59 3.29 ± 0.34 0.552
ChP2 5.16 ± 0.41 4.24 ± 0.27 3.82 ± 0.56 3.28 ± 0.62 3.18 ± 0.23
BOP (%) ChP1 57 ± 0.53 29.12 ± 17.21 0.432 27.15 ± 18.11 26.13 ± 17.31 0.22 27.14 ± 15.66 0.232
ChP2 59 ± 0.55 34.14 ± 16.71 32.17 ± 16.51 31.12 ± 15.51 28.14 ± 16.63
PI ChP1 2.43 ± 0.11 0.66 ± 0.13 0.363 0.62 ± 0.14 0.334 0.58 ± 0.11 0.38 0.54 ± 0.13 0.343
ChP2 2.46 ± 0.13 0.67 ± 0.12 0.61 ± 0.16 0.56 ± 0.09 0.55 ± 0.12
GI ChP1 2.33 ± 0.13 1.58 ± 0.11 0.151 1.23 ± 0.09 0.181 1.15 ± 0.11 0.114 1.14 ± 0.12 0.125
ChP2 2.38 ± 0.16 1.55 ± 0.14 1.16 ± 0.16 1.13 ± 0.17 1.12 ± 0.18

S.D - standard deviation, PD = probing depth; CAL = clinical attachment level; BOP = bleeding on probing; PI = plaque index; GI = gingival index, * Anova, Statistically significant at p < 0.05.